Ken Fisher's CPRX Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 83,137 shares of Catalyst Pharmaceuticals, Inc. (CPRX) worth $1.64 M, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in CPRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2021, adding 63,751 shares. Largest reduction occurred in Q4 2022, reducing 157,329 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Catalyst Pharmaceuticals (CPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Catalyst Pharmaceuticals (CPRX) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2021 | +201,801 | New Buy | 201,801 | $5.30 |
| Q4 2021 | +63,751 | Add 31.59% | 265,552 | $6.77 |
| Q1 2022 | -5,084 | Reduce 1.91% | 260,468 | $8.29 |
| Q2 2022 | +30,429 | Add 11.68% | 290,897 | $7.01 |
| Q4 2022 | -157,329 | Reduce 54.08% | 133,568 | $18.60 |
| Q1 2023 | -21,904 | Reduce 16.40% | 111,664 | $16.58 |
| Q1 2024 | +955 | Add 0.86% | 112,619 | $15.94 |
| Q2 2024 | -7,084 | Reduce 6.29% | 105,535 | $15.49 |
| Q3 2024 | -18,738 | Reduce 17.76% | 86,797 | $19.88 |
| Q4 2024 | +50 | Add 0.06% | 86,847 | $20.87 |
| Q1 2025 | -4,679 | Reduce 5.39% | 82,168 | $24.25 |
| Q2 2025 | +969 | Add 1.18% | 83,137 | $21.70 |
Ken Fisher's Catalyst Pharmaceuticals Investment FAQs
Ken Fisher first purchased Catalyst Pharmaceuticals, Inc. (CPRX) in Q3 2021, acquiring 201,801 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Catalyst Pharmaceuticals, Inc. (CPRX) for 17 quarters since Q3 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to Catalyst Pharmaceuticals, Inc. (CPRX) was in Q3 2021, adding 201,801 shares worth $1.07 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 83,137 shares of Catalyst Pharmaceuticals, Inc. (CPRX), valued at approximately $1.64 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Catalyst Pharmaceuticals, Inc. (CPRX) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in Catalyst Pharmaceuticals, Inc. (CPRX) was 290,897 shares, as reported at the end of Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.